Press Releases Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:05:42 2026-01-20 am EST			5-day change	1st Jan Change
1,609.10 ^INR	-3.96%		-7.29%	-6.41%

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI

Press Releases

Jan. 16	Sun Pharma Announces the Availability of UNLOXCYT for Advanced Cutaneous Squamous Cell Carcinoma	AQ
Jan. 02	Sun Pharma Launches ILUMYA® In India	AQ
Dec. 01	Sun Pharma introduces its global innovative drug, Ilumya in India for treatment of moderate-to-severe Plaque Psoriasis	AQ
25-07-14	Delhi HC Rejects CBDT's Endeavor Of Prescribing Limitation Through A Circular In The Absence Of Statutory Backing	AQ
25-06-16	Sun Pharma appoints Kirti Ganorkar as the Managing Director, Dilip Shanghvi to continue as the Executive Chairman of the Board	AQ
25-06-12	Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.	AQ
25-04-25	Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage	AQ
24-11-25	Healthcare \| July And August 2024 - Case Laws	AQ
24-11-13	Analysis Group - Reports by Managing Principal John Jarosz Cited in Grant of Preliminary Injunction in Patent Infringement Case	AQ
24-10-28	Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference	AQ
24-10-02	Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUN	AQ
24-09-09	Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain	AQ
24-06-17	Sun Pharma - Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis	AQ
24-05-23	Taro Shareholders Approve Merger with Sun Pharma	AQ
24-05-09	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	AQ
23-09-27	Sun Pharma Canada Launches (PR)WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne	AQ
23-09-14	Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi in India	AQ
23-09-13	Another US Patent Litigation Win For Orexo AB's ZUBSOLV®	AQ
23-07-24	Orexo's patent win for ZUBSOLV[®] appealed	AQ
23-07-03	Orexo wins patent litigation for ZUBSOLV in the US	AQ
23-07-01	Orexo wins patent litigation for ZUBSOLV® in the US	AQ
23-06-26	Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne	AQ
23-05-31	Sun Pharma Announces China NMPA Approval for ILUMETRI for Treatment of Adults with Moderate-To-Severe Plaque Psoriasis	AQ
23-05-31	Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY in Europe, Australia and New Zealand	AQ
23-03-20	SUN PHARMA - LATE-BREAKING PHASE 3 DATA AT AAD 2023 SHOW ORAL INVESTIGATIONAL MEDICINE DEURUXOLITINIB SIGNIFICANTLY IMPROVED SCALP HAIR REGROWTH IN ALOPECIA AREATA	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Press Releases

Filters